333 related articles for article (PubMed ID: 17121523)
21. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
22. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
[TBL] [Abstract][Full Text] [Related]
23. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
25. Micromedullary thyroid cancer: how micro is truly micro?
Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
[TBL] [Abstract][Full Text] [Related]
26. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V
B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930
[TBL] [Abstract][Full Text] [Related]
27. [Type of surgery for 147 patients with medullary carcinoma of the thyroid].
Huang CP; Zhu YX; Tian AL
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):490-2. PubMed ID: 14575577
[TBL] [Abstract][Full Text] [Related]
28. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
29. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
30. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.
Dottorini ME; Assi A; Sironi M; Sangalli G; Spreafico G; Colombo L
Cancer; 1996 Apr; 77(8):1556-65. PubMed ID: 8608543
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group.
Bergholm U; Adami HO; Bergström R; Bäckdahl M; Akerström G
Acta Chir Scand; 1990 Jan; 156(1):37-46. PubMed ID: 2321439
[TBL] [Abstract][Full Text] [Related]
32. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors of survival in medullary cancers of the thyroid. Apropos of 51 cases. Clinical, biochemical and immunocytochemical study].
Goudet P; Rogissart F; Petit JM; Vaillant G; Durnerin I; Fraisse J; Justrabo E; Verges B; Cougard P
Ann Chir; 1996; 50(1):23-9. PubMed ID: 8734273
[TBL] [Abstract][Full Text] [Related]
34. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
Machens A; Hauptmann S; Dralle H
Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
[TBL] [Abstract][Full Text] [Related]
35. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
[TBL] [Abstract][Full Text] [Related]
36. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
37. Extrathyroidal extension in well-differentiated thyroid cancer: macroscopic vs microscopic as a predictor of outcome.
Hu A; Clark J; Payne RJ; Eski S; Walfish PG; Freeman JL
Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):644-9. PubMed ID: 17638775
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
39. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR
Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
